These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6058900)

  • 1. Distribution excretion and metabolism of neuroleptics of the butyrophenone type. II. Distribution, excretion and metabolism of haloperidol in Sprague-Dawley rats.
    Braun GA; Poos GI; Soudijn W
    Eur J Pharmacol; 1967 Jan; 1(1):58-62. PubMed ID: 6058900
    [No Abstract]   [Full Text] [Related]  

  • 2. Distribution, excretion and metabolism of neuroleptics of the butyrophenone type. I. Excretion and metabolism of haloperidol and nine related butyrophenone-derivatives in the Wistar rat.
    Soudijn W; Van Wijngaarden I; Allewijn F
    Eur J Pharmacol; 1967 Jan; 1(1):47-57. PubMed ID: 6058899
    [No Abstract]   [Full Text] [Related]  

  • 3. Distribution and metabolism of neuroleptic drugs. I. Pharmacokinetics of haloperidol.
    Lewi PJ; Heykants JJ; Allewijn FT; Dony JG; Janssen PA
    Arzneimittelforschung; 1970 Jul; 20(7):943-8. PubMed ID: 5536066
    [No Abstract]   [Full Text] [Related]  

  • 4. Disposition and metabolism of [14C]-haloperidol in rats.
    Miyazaki H; Matsunaga Y; Nambu K; Oh-e Y; Yoshida K; Hashimoto M
    Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The distribution of the butyrophenones haloperidol, trifluperidol, moperone, and clofluperol in rats, and its relationship with their neuroleptic activity.
    Janssen PA; Allewijn FT
    Arzneimittelforschung; 1969 Feb; 19(2):199-208. PubMed ID: 5818759
    [No Abstract]   [Full Text] [Related]  

  • 6. Excretion and metabolism of intramuscularly administered [14C]-haloperidol decanoate in rats.
    Matsunaga Y; Nambu K; Oh-e Y; Miyazaki H; Hashimoto M
    Arzneimittelforschung; 1986 Mar; 36(3):453-6. PubMed ID: 3707664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computer procedures for evaluating the results of studies on the distribution and metabolism of drugs in the body.
    Lewi PJ; Chandler AE; van Riel DG; Somers PJ; Allewijn FT; Dony JG; Janssen PA
    Arzneimittelforschung; 1970 May; 20(5):684-93. PubMed ID: 5468058
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolism and excretion of tritiated dextromethorphan by the rat.
    Kamm JJ; Taddeo AB; Van Loon EJ
    J Pharmacol Exp Ther; 1967 Dec; 158(3):437-44. PubMed ID: 6073227
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies on cardiovascular drugs. 3. Absorption, distribution, excretion and metabolism of 8-((1,4-benzodioxane-2-yl) methyl)-3-oxo-1-thia-4,8-diazaspiro (4,5) decane maleate (Y-3506)].
    Imamura H; Matsui E; Kato Y; Furuta T
    Yakugaku Zasshi; 1971 Aug; 91(8):811-7. PubMed ID: 5164985
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative studies on distribution, excretion, and metabolism of hydroxyzine-3H and its methiodide-14C in rats.
    Pong SF; Huang CL
    J Pharm Sci; 1974 Oct; 63(10):1527-32. PubMed ID: 4436782
    [No Abstract]   [Full Text] [Related]  

  • 11. Absorption and excretion of tritiated haloperidol in man. (A preliminary report).
    Johnson PC; Charalampous KD; Braun GA
    Int J Neuropsychiatry; 1967 Aug; 3():Suppl 1:24-5. PubMed ID: 6051722
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolism of 6-chloro-5-cyclohexylindane-1-carboxylic acid (TAI-284), a new non-steroidal anti-inflammatory agent. I. Absorption, distribution and excretion in rats.
    Tanayama S; Tsuchida E; Suzuoki Z
    Xenobiotica; 1973 Oct; 3(10):643-56. PubMed ID: 4774631
    [No Abstract]   [Full Text] [Related]  

  • 13. [Absorption, distribution, metabolism and excretion of rifampicin (3-(4-methyl-1-piperazinyl-iminomethyl) rifamycin SV) in the rat].
    Akimoto T; Ono K; Nanpo T
    Jpn J Antibiot; 1970 Jun; 23(3):250-6. PubMed ID: 5312377
    [No Abstract]   [Full Text] [Related]  

  • 14. The distribution and metabolic fate of xyloxemine hydrochloride in mice and rats.
    Hespe W; Prins H; Kafoe WF; Nauta WT
    Arch Int Pharmacodyn Ther; 1967 Dec; 170(2):397-408. PubMed ID: 6076587
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diagnosis of bile metabolism disorders].
    Blum AL; Kreis GJ; Brändi HH; Benes I; Ammann R; Knoblauch M
    Dtsch Med Wochenschr; 1974 Feb; 99(7):290 passim. PubMed ID: 4818225
    [No Abstract]   [Full Text] [Related]  

  • 16. Clearance from plasma and excretion in urine, faeces and bile of an intravenous dose of tritiated vitamin K 1 in man.
    Shearer MJ; Mallinson CN; Webster GR; Barkhan P
    Br J Haematol; 1972 May; 22(5):579-88. PubMed ID: 5032096
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolism, distribution and excretion of flupenthixol.
    Jorgensen A; Hansen V; Larsen UD; Khan AR
    Acta Pharmacol Toxicol (Copenh); 1969; 27(4):301-13. PubMed ID: 5394747
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolism of steroid and amino acid moieties of conjugated bile acids in man. II. Glycine-conjugated dihydroxy bile acids.
    Hepner GW; Hofmann AF; Thomas PJ
    J Clin Invest; 1972 Jul; 51(7):1898-905. PubMed ID: 5032530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The excretion of 3H-papaverine in the rat.
    Belpaire FM; Bogaert MG
    Biochem Pharmacol; 1973 Jan; 22(1):59-66. PubMed ID: 4763245
    [No Abstract]   [Full Text] [Related]  

  • 20. Cefazolin, a new semisynthetic cephalosporin antibiotic. VI. Excretion and metabolism of cefazolin- 14 C in rats after intramuscular administration.
    Kozatani J; Okui M; Matsubara T; Nishida M
    J Antibiot (Tokyo); 1972 Feb; 25(2):86-93. PubMed ID: 5034810
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.